Recombinant Human Mucin-19 (MUC19)

Shipped with Ice Packs
In Stock

Description

Expression and Location

  • Salivary Glands: MUC19 is found in the salivary glands and saliva, where it participates in innate immune functions against oral pathogens like Streptococcus mutans . Although MUC19 is expressed in human saliva, research suggests that it is not a major component .

  • Middle Ear: MUC19 expression occurs in the middle ear epithelium, where its expression changes in response to inflammatory cytokines such as TNF-$$\alpha$$ .

  • Respiratory Tract: MUC19 is expressed in the respiratory tract and contributes to the pathogenesis of diseases such as chronic rhinosinusitis and human metapneumovirus (HMPV) infection .

Functional Roles

  • Innate Immunity: In the oral cavity, MUC19 aids in the clearance of bacteria like Streptococcus mutans, limiting their colonization through aggregation and formation of complexes with other salivary constituents .

  • Response to Inflammation: MUC19 expression can be modulated by inflammatory cytokines. For instance, TNF-$$\alpha$$ increases MUC19 expression in middle ear epithelial cells . IL-19 upregulates MUC5AC-induced mucin production via the STAT3 pathway in chronic rhinosinusitis .

  • Contribution to Disease Pathogenesis: MUC19 contributes to the development of diseases like chronic rhinosinusitis (CRS) and HMPV-induced disease . Studies have shown that MUC19 influences the severity of HMPV infections and affects CD4+ T-cell responses .

MUC19 and Chronic Rhinosinusitis (CRS)

In patients with CRS, both MUC19 and IL-19 expressions are elevated within the epithelial cells of the mucosa . IL-19 promotes MUC5AC expression, which leads to increased mucin production via the STAT3 pathway. The relationship between IL-19 and MUC5AC suggests that IL-19 plays a significant role in the pathogenesis of CRS .

MUC19 and Human Metapneumovirus (HMPV)

Research indicates that MUC19 contributes to HMPV-induced disease. Studies using Muc19 knockout mice have demonstrated that the absence of MUC19 leads to reduced weight loss and lower viral titers in the lungs following HMPV infection, suggesting MUC19 plays a role in HMPV pathogenesis .

MUC19 Modulation and Therapeutic Potential

As MUC19 is involved in various diseases, finding ways to modulate its expression could have therapeutic benefits. For example, a study identified fostamatinib as a potential drug for repurposing in acute lung injury (ALI) treatment because it reduces Mucin-1 (MUC1) protein abundance . While this study focuses on MUC1, the concept highlights the potential for targeting mucins to treat respiratory diseases .

Research Techniques

The study of MUC19 involves a variety of techniques to understand its expression, function, and interactions. These techniques include:

  • Real-time quantitative PCR: Used to measure mRNA expression levels .

  • ELISA and Confocal Microscopy: Utilized to measure protein concentrations .

  • Immunohistochemistry: Used to detect the presence and localization of MUC19 in tissue samples .

  • Western Blot: Employed to measure protein expression and phosphorylation levels .

  • Methylcellulose Plaque Assay: Used to quantify infectious viral particles .

  • High-Content Screening: Used to identify compounds that reduce mucin expression .

MUC19 Interactions

S. mutans interactions (i.e., adherence, aggregation, and biofilm formation) demonstrate Muc19 poorly aggregates S. mutans . Nonetheless, aggregation is enhanced upon adding Muc19 to saliva from Muc19 -/- mice, indicating Muc19 assists in bacterial clearance through the formation of heterotypic complexes with salivary constituents that bind S. mutans .

Data Tables

Table 1: MUC19 Expression in Different Tissues

TissueExpression LevelRole/FunctionReference
Salivary GlandsPresentAids in bacterial clearance and innate immunity against oral pathogens
Middle EarPresentResponds to inflammatory cytokines
Respiratory TractPresentContributes to the pathogenesis of CRS and HMPV-induced respiratory diseases

Table 2: Impact of IL-19 on MUC5AC Expression in CRS

ConditionMUC5AC ExpressionMechanismReference
PHNECs treated with rhIL-19IncreasedIL-19 upregulates MUC5AC via the STAT3 pathway
IL-20R2 siRNA transfected PHNECsDecreasedKnockdown of IL-20R2 interferes with IL-19 activity
PHNECs pretreated with CRY (STAT3 inhibitor)SuppressedCRY inhibits the STAT3 pathway, reducing MUC5AC production

Table 3: Effect of MUC19 on HMPV Infection

ConditionWeight LossLung Viral TitersReference
Wild-type miceHigherHigher
Muc19 knockout miceLowerLower

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The specific tag type is determined during production. If a specific tag is required, please inform us for preferential development.
Synonyms
MUC19; Mucin-19; MUC-19
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
-
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Homo sapiens (Human)
Target Names
MUC19
Uniprot No.

Target Background

Function
Potentially involved in ocular mucus homeostasis.
Gene References Into Functions
  1. Polymorphic variants in the MUC19 gene may contribute to asthma susceptibility in individuals of Russian ethnicity. PMID: 26845862
  2. MUC19 transcripts and glycoproteins have been detected in salivary glands and saliva. PMID: 25512380
  3. A single-nucleotide polymorphism in the MUC19 gene shows association with Crohn's disease. PMID: 23619718
  4. MUC19 presence suggests mucoepidermoid carcinoma. PMID: 21072847
  5. Observational study of gene-disease association (HuGE Navigator). PMID: 21072187
  6. Clinical trial on gene-disease association and gene-environment interaction (HuGE Navigator). PMID: 20379614
  7. Germline variation in MUC19 is not linked to the genome-wide significant association of the 12q12 locus with Crohn's disease. PMID: 19714762
  8. MUC19 may play a role in middle ear physiology and pathophysiology. PMID: 19533339
  9. Identification, cloning, and expression of mucin 19; its expression is restricted to mucous cells in various glandular tissues. PMID: 12882755
  10. MUC19 is not a major component of human saliva. PMID: 18426393
  11. Reflux laryngitis is associated with down-regulation of mucin gene expression. PMID: 18834073
  12. Observational study of gene-disease association (HuGE Navigator). PMID: 19068216
Database Links

HGNC: 14362

OMIM: 612170

KEGG: hsa:283463

STRING: 9606.ENSP00000395253

UniGene: Hs.632712

Subcellular Location
Secreted.
Tissue Specificity
Expressed corneal epithelial cells, conjunctival goblet and epithelial cells and lacrimal gland cells (at protein level). Expressed by mucous cells of the submandibular gland and submucosal gland of the trachea. Expressed by middle ear epithelial cells.

Q&A

What is Human MUC19 and what is its role in human physiology?

MUC19 is a gel-forming mucin glycoprotein responsible for contributing to the viscoelastic properties of mucus in various tissues. It plays critical roles in epithelial homeostasis and innate defense systems across multiple body sites. The protein is involved in creating protective barriers that lubricate epithelial surfaces and trap potential pathogens, preventing infections particularly in the respiratory tract. MUC19 expression is associated with gland function in humans, which represents an important component of immune response, particularly in mucus formation in tracheal submucosal glands that help prevent pathogenic infections .

Where is MUC19 predominantly expressed in human tissues?

MUC19 is predominantly expressed in tracheal submucosal glands and salivary glands. This expression pattern has been confirmed through antibody staining using antibodies developed against either the amino (N) or carboxy (C) terminus of MUC19, which demonstrated similar staining patterns in both salivary and tracheal submucosal glands . Beyond these primary sites, elevated MUC19 expression has been documented in nasal epithelial cells of patients with allergic rhinitis and in middle ear epithelium from patients with recurrent otitis media or chronic otitis media with effusion, suggesting a potential role in inflammatory responses in these tissues .

What evolutionary history does the MUC19 gene have in humans?

MUC19 has a fascinating evolutionary history that involves archaic human species. Research has revealed that some modern humans carry a Denisovan-like haplotype of MUC19, found at particularly high frequencies in admixed Latin American individuals and at the highest frequency in ancient Indigenous American individuals predating European and African admixture . Interestingly, some Neanderthals (specifically the Vindija and Chagyrskaya specimens) also carried this Denisovan-like MUC19 haplotype, suggesting it likely entered modern human populations through Neanderthal rather than direct Denisovan introgression . A key feature of the Denisovan-like MUC19 haplotype is its higher copy number of a 30 base-pair VNTR compared to the Human-like haplotype, with American populations showing remarkably high copy numbers .

What experimental techniques are most effective for studying recombinant MUC19 expression?

Recombinant expression of MUC19 requires specialized approaches due to its large size and complex post-translational modifications. Based on research methodologies, the following approaches have proven effective:

  • For antibody development: Expression of the N-terminal or C-terminal regions has been successful for generating specific antibodies against MUC19. These antibodies have been effectively used in immunofluorescence studies of human trachea and salivary gland tissues .

  • For tissue expression analysis: Paraformaldehyde fixation followed by paraffin embedding of tissues, with subsequent sectioning and immunostaining using anti-MUC19 antibodies has provided reliable results for visualizing MUC19 expression patterns. Confocal microscopy techniques allow for high-resolution imaging of MUC19 localization .

  • For primary cell culture studies: Methods similar to those used for MUC5AC studies can be adapted, including isolation of primary human nasal epithelial cells from tissue samples, culture in appropriate growth medium, and stimulation with relevant factors to study MUC19 regulation .

  • For genetic manipulation: RNA interference approaches using siRNA technology can be employed to selectively knock down MUC19 expression, similar to methodologies used for IL-20R2 knockdown in MUC5AC studies .

How does the copy number variation in MUC19 tandem repeats affect its biological function?

The VNTR of the 30 base-pair motif in MUC19's PTS domain shows significant variation between human populations and likely affects the protein's biological properties and function . Research has revealed striking differences in repeat copy numbers:

  • Individuals carrying the Denisovan-like MUC19 haplotype present significantly higher numbers of repeats (approximately 417 copies on average in admixed individuals from the Americas) compared to those with the Human-like haplotype .

  • Non-American populations typically show fewer repeats, ranging from an average of 345 to 355 copies .

This variation in repeat copy number likely influences the biochemical and functional properties of the MUC19 protein. By analogy with other mucins such as MUC7, where different numbers of PTS repeats correlate with altered microbe-binding properties, the MUC19 variants likely differ in their molecular binding affinities and functional capacities . These differences may affect pathogen binding, clearance mechanisms, or the viscoelastic properties of mucus, potentially explaining why positive selection appears to have increased the frequency of the Denisovan-like haplotype in certain populations .

What are the regulatory mechanisms controlling MUC19 expression in airway diseases?

While specific regulatory mechanisms for MUC19 in airway diseases are not fully characterized, research findings provide insights by analogy with related mucins:

  • Inflammatory cytokines likely play a critical role in regulating MUC19 expression, as MUC19 shows altered expression in cytokine-challenged middle ear epithelium and in allergic mouse models .

  • Based on studies of MUC5AC (another important airway mucin), the IL-19/IL-20 receptor/STAT3 signaling axis may represent a key regulatory pathway for MUC19. IL-19 has been shown to significantly upregulate MUC5AC expression in primary human nasal epithelial cells through STAT3 activation .

  • The regulation appears to involve specific receptor-mediated processes, as demonstrated by the reduction in mucin expression when IL-20R2 (a component of the IL-19 receptor) is knocked down by siRNA .

  • STAT3 signaling represents a critical downstream pathway, as inhibition of STAT3 with cryptotanshinone reduces mucin production even in the presence of stimulatory cytokines like IL-19 .

Understanding these regulatory mechanisms is essential for developing targeted therapies for airway diseases characterized by mucus hypersecretion, potentially including approaches that modulate MUC19 expression.

How do MUC19 variants impact susceptibility to respiratory pathogens?

While direct experimental evidence specifically linking MUC19 variants to pathogen susceptibility is limited, evolutionary and comparative analyses provide valuable insights:

  • The elevated frequency of the Denisovan-like MUC19 haplotype in American populations suggests positive selection, potentially related to adaptation to novel environmental challenges including pathogen exposure during human migration through different environments .

  • The different number of tandem repeats between Human-like and Denisovan-like haplotypes likely affects the binding properties of MUC19. In other mucins such as MUC7, variation in tandem repeat numbers correlates with different microbe-binding properties .

  • The functional role of MUC19 in tracheal submucosal glands suggests it contributes to preventing pathogenic infections in the respiratory tract .

  • MUC19 expression changes have been documented in inflammatory conditions including allergic rhinitis and otitis media, suggesting its involvement in the response to pathogenic challenges .

These observations collectively suggest that variants of MUC19 may influence susceptibility to respiratory pathogens, though further experimental validation is needed to establish direct functional relationships.

What are the optimal techniques for isolating and characterizing MUC19 from biological samples?

Isolating and characterizing MUC19 from biological samples presents technical challenges due to its large size and extensive glycosylation. Based on methodologies in the research literature, the following approaches are recommended:

  • Tissue preparation and fixation:

    • Human trachea or salivary gland tissues should be fixed in 4% paraformaldehyde before embedding in paraffin

    • Sections should be prepared at approximately 4 μm thickness for optimal antibody penetration and signal detection

  • Immunodetection protocols:

    • Incubate tissue sections with anti-MUC19 antibodies (typically 1:100 dilution) overnight at 4°C

    • Use appropriate secondary antibodies combined with detection systems such as TSA plus fluorescein kit

    • Acquire images using confocal microscopy for detailed localization

  • RNA expression analysis:

    • Extract total RNA using methods based on phenol and guanidine isothiocyanate

    • Perform RT-PCR using specific primers designed to unique regions of MUC19

    • Normalize data to appropriate housekeeping genes for accurate quantification

  • Protein characterization:

    • For Western blotting, special consideration must be given to the large size of MUC19

    • Use gradient gels or specialized electrophoresis systems designed for high molecular weight proteins

    • Employ antibodies targeting either the N-terminal or C-terminal regions for detection

What cell culture models are most appropriate for studying MUC19 function?

Several cell culture models can be effectively employed to study MUC19 function, each with specific advantages:

  • Primary human nasal epithelial cells (PHNECs):

    • Isolated from nasal polyps or other airway tissues using protease digestion

    • Cultured in bronchial epithelial growth medium (BEGM) at appropriate cell density

    • Can be stimulated with cytokines or other factors to study MUC19 regulation

    • Allow for genetic manipulation using siRNA transfection to modulate expression of MUC19 or regulatory factors

  • Air-liquid interface (ALI) cultures:

    • More physiologically relevant than submerged cultures

    • Allow for proper differentiation of airway epithelial cells, including mucin-producing goblet cells

    • Enable study of MUC19 in a polarized epithelium that more closely resembles in vivo conditions

  • Salivary gland cell models:

    • Particularly relevant for studying MUC19 function in salivary secretions

    • Can be derived from human salivary gland biopsies or established cell lines

    • Allow for investigation of MUC19's role in salivary fluid properties and gland function

  • Transfected cell lines expressing recombinant MUC19:

    • Enable controlled studies of specific MUC19 variants

    • Facilitate investigation of structure-function relationships

    • Allow comparison between Denisovan-like and Human-like MUC19 haplotypes

What RNA analysis techniques are most reliable for quantifying MUC19 expression?

Accurate quantification of MUC19 expression at the RNA level requires specific considerations due to the gene's complex structure and repetitive regions:

  • Primer design considerations:

    • Primers should target unique regions of the MUC19 gene outside the repetitive sequences

    • Design primers that span exon-exon junctions to avoid genomic DNA amplification

    • Validate primers for specificity through sequencing of PCR products

  • Quantitative RT-PCR protocol:

    • Total RNA isolation using methods based on phenol and guanidine isothiocyanate

    • First-strand cDNA synthesis using oligo(dT) or random primers

    • SYBR Green-based or probe-based qPCR with appropriate cycling conditions

    • Typical conditions: 45 cycles at 95°C for 30s, 95°C for 15s, 60°C for 30s, and 72°C for 1min

  • Reference gene selection:

    • Use multiple reference genes for accurate normalization

    • β2-microglobulin (β2M) and GAPDH have been used successfully in related studies

    • Verify stability of reference genes across experimental conditions

  • RNA quality assessment:

    • Confirm RNA integrity using bioanalyzer or gel electrophoresis

    • Assess purity through A260/A280 and A260/A230 ratios

    • Include no-RT controls to detect genomic DNA contamination

What methods can be used to analyze MUC19 tandem repeat copy numbers?

The analysis of MUC19 tandem repeat copy numbers requires specialized approaches to accurately quantify these highly repetitive regions:

  • Next-generation sequencing approaches:

    • Whole genome sequencing with sufficient depth to cover repetitive regions

    • Targeted sequencing focusing on the MUC19 locus

    • Long-read sequencing technologies (PacBio, Oxford Nanopore) to span repetitive regions

  • Computational analysis:

    • Specialized algorithms designed to handle tandem repeat copy number estimation

    • Comparative analysis between samples to identify relative differences in copy number

    • Population genetics approaches to study distribution patterns

  • PCR-based methods:

    • Digital droplet PCR for absolute quantification of copy numbers

    • Long-range PCR to amplify across repetitive regions

    • Design of primers flanking the repeat region to assess size differences

What is the population distribution of MUC19 haplotypes and tandem repeat copy numbers?

Research has revealed significant population differences in MUC19 haplotypes and tandem repeat copy numbers:

PopulationDenisovan-like MUC19 Haplotype FrequencyAverage VNTR Copy Number
Ancient Indigenous AmericansHighest frequencyNot specifically reported
Admixed Latin AmericansHigh frequency~417 copies
Non-American populationsLower frequency345-355 copies

These findings indicate that the Denisovan-like MUC19 haplotype is particularly prevalent in Indigenous American populations and their descendants. This haplotype is characterized by significantly higher numbers of the 30bp tandem repeat compared to the Human-like haplotype . The distribution pattern suggests positive selection for the Denisovan-like haplotype in American populations, potentially related to adaptation to environmental factors encountered during migration from Beringia into North and South America .

How can researchers differentiate between Denisovan-like and Human-like MUC19 haplotypes?

Differentiating between Denisovan-like and Human-like MUC19 haplotypes requires specific genetic markers and analytical approaches:

  • Diagnostic variants:

    • Specific single nucleotide polymorphisms (SNPs) serve as diagnostic markers for the Denisovan-like haplotype

    • These variants can be detected through targeted genotyping or sequencing approaches

  • Tandem repeat analysis:

    • The Denisovan-like haplotype typically contains significantly more copies of the 30bp tandem repeat

    • Quantitative analysis of repeat copy number can help distinguish between haplotypes

  • Haplotype analysis:

    • Examination of linked variants across the MUC19 locus

    • Comparison with reference sequences from Denisovan and Neanderthal genomes

  • Functional differentials:

    • Potential differences in glycosylation patterns between variants

    • Variations in molecular binding properties related to different repeat numbers

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.